taper_shift
TL3 Regular · Nijmegen, NL
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 10 August 2024 · last posted 10d · groups: journal-club
110 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #40 · Access › Insurance & coverage · 18 Jul 2026 · 9 likes That is a fair summary of where the discussion has got to.
-
Restarting after a long gap: what the labelling implies Replied, post #28 · Practice › Dosing & titration · 16 Jul 2026 · 1 like I had written a reply contradicting post #24 and deleted it. Here is what survived. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #105 · Evidence › Journal club · 14 Jul 2026 · 26 likes I came in to disagree and I am leaving without a disagreement.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #25 · Access › Insurance & coverage · 13 Jul 2026 · 11 likes What does not work: describing how the decision made you feel, however justified. The reviewer is checking criteria and the job is to make them checkable. Posting it…
-
Insurance and replacement policies, compared Replied, post #85 · Sourcing › Logistics · 13 Jul 2026 · 24 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #70 · Analytics › Home & field testing · 11 Jul 2026 · 2 likes Taking post #67 at face value and following it one step further. Nobody has said the unglamorous part of Reflectance and photometric devices yet, so: most of the…
-
Follow-up: Signs of dehydration worth acting on Replied, post #18 · Safety › Adverse events · 8 Jul 2026 · 15 likes Narrowing post #17, because the general version has more than one answer. Reading back through the Signs of dehydration worth acting threads from last year, the same…
-
Second pass at: The storage lookup and where its data comes from Replied, post #39 · Data & Tools › Calculators · 1 Jul 2026 · 4 likes Understood. Thank you for being specific about the limits of it.
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #14 · Analytics › Home & field testing · 1 Jul 2026 · 0 likes Following this. I have the same question and no better information than the first post.
-
Reading a home test result without over-claiming Replied, post #100 · Analytics › Home & field testing · 30 Jun 2026 · 16 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #18 · Nutrition & Training › Protein & intake · 29 Jun 2026 · 13 likes Everything in post #15 holds. The case it does not cover is the one I have. Meeting protein targets on suppressed appetite: this is where the practical difficulty lies.…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #38 · Access › Insurance & coverage · 25 Jun 2026 · 0 likes Date every account in this subcategory. Payer criteria change frequently and the archive keeps posts permanently. I am describing what is, rather than arguing for what…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #8 · Nutrition & Training › Protein & intake · 25 Jun 2026 · 4 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Protein supplements: whey, casein, and plant-based protein powders can help hit…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #69 · Practice › Reconstitution · 3 Jun 2026 · 7 likes Where I part company with post #65, and it is a narrow parting. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Pooling trials with different estimands Replied, post #3 · marked as the solution · Evidence › Meta-analyses · 1 Jun 2026 · 7 likes Taking pooling trials with different estimands seriously for a moment rather than deflecting: the honest position is that the community has observations and no…
-
Five questions in one post gets you one answer — how to split them Replied, post #90 · Start Here › How to Ask · 25 May 2026 · 0 likes Coming back to post #88, because the follow-up matters more than the original answer. Questions you cannot explain: "I cannot say why I am asking this, but is this…
-
Documenting a supplier's response to a discrepancy Replied, post #2 · Sourcing › Vendor reports · 23 May 2026 · 0 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
-
Follow-up: Search filters: what is missing Replied, post #99 · Meta › Site feedback · 11 May 2026 · 5 likes Post #95 put the caveat in the right place and I want to underline it. Feedback on the search: the status filter is the most useful control on the site and it is the…
-
A 40-week log with the measurement method stated — what changed since Replied, post #3 · Outcomes › Progress reports · 5 May 2026 · 29 likes Weighing daily and reporting weekly is a better protocol than weighing weekly, because it separates the measurement frequency from the reporting frequency.
-
What a good consultation looks like from the other side Replied, post #35 · Clinical › Prescriber conversations · 26 Apr 2026 · 5 likes I read post #31 twice before replying, because I had assumed the opposite. The reason good consultation keeps being re-asked is that the answer is conditional and…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #114 · Pharmacology › Pharmacokinetics · 22 Apr 2026 · 1 like On post #110 — agreed on the reasoning, with one qualification. Where two sources give different half-lives, check the study design before deciding either is wrong.…
-
How to ask about something you suspect is a bad idea Replied, post #78 · Start Here › How to Ask · 18 Apr 2026 · 26 likes Say what you have already ruled out. "It is not the diluent because I tried a second vial from a different box" saves three replies suggesting the diluent.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #8 · Analytics › Method validation · 18 Apr 2026 · 0 likes The bit of specificity that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Conditions that change the calculus rather than forbidding it Replied, post #9 · Safety › Contraindications · 16 Apr 2026 · 19 likes Where a condition appears as a warning rather than a contraindication, the decision is a clinical one rather than a prohibition. That is what I would do. It may not be…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #58 · Data & Tools › Calculators · 9 Apr 2026 · 8 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places. I…
-
Follow-up: State-level differences that actually matter Replied, post #89 · Regional › North America · 8 Apr 2026 · 0 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.…
-
Spike-and-recover accuracy for a peptide assay Replied, post #11 · Analytics › Method validation · 7 Apr 2026 · 30 likes Noted, and thank you for writing it out rather than summarising it.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #71 · Clinical › Special populations · 13 Mar 2026 · 0 likes Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how much. A weak preference rather than a position.
-
Reused chromatograms across lots: how to spot it Replied, post #26 · Analytics › COA interpretation · 12 Mar 2026 · 10 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #141 · Analytics › COA interpretation · 27 Feb 2026 · 18 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #100 · Access › Pricing · 26 Feb 2026 · 14 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #72 · Evidence › Study critique · 21 Feb 2026 · 0 likes Attrition is the failure mode most likely to invalidate a result and the least likely to be discussed. Differential attrition between arms is the specific thing to look…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #114 · Practice › Interactions · 18 Feb 2026 · 21 likes Coming back to post #110, because the follow-up matters more than the original answer. The bit of Warfarin and altered intake that nobody enjoys is that the answer…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #43 · Practice › Side effects · 6 Feb 2026 · 5 likes Answering the Dizziness on standing question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the…
-
[2026 update] What a purity-only report leaves out Replied, post #13 · Sourcing › Independent verification · 31 Jan 2026 · 17 likes My experience of purity-only contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #41 · Evidence › Trials · 30 Jan 2026 · 15 likes A definition problem is doing most of the work in this non-inferiority margins discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #13 · Evidence › Trials · 23 Jan 2026 · 8 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Moderation log format change Replied, post #20 · Meta › Announcements · 9 Jan 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Angle of injection and whether 90 degrees is always right Replied, post #75 · Practice › Administration · 1 Jan 2026 · 3 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #49 · Compounds › Semaglutide · 27 Dec 2025 · 3 likes I read post #45 twice before replying, because I had assumed the opposite. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is…
-
Tracking a preprint to publication: a worked example Replied, post #42 · Evidence › Preprints · 4 Dec 2025 · 0 likes Narrowing post #39, because the general version has more than one answer. Reading a preprint properly means doing some of the reviewer's job: methods first, then…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #15 · Safety › Contraindications · 1 Dec 2025 · 3 likes Severe renal impairment (eGFR I am not the right person to answer the follow-up to this.
-
The headache that turns out to be dehydration Replied, post #72 · Nutrition & Training › Hydration & electrolytes · 27 Nov 2025 · 23 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #45 · Compounds › Other compounds · 24 Nov 2025 · 2 likes The arithmetic in post #43 is right; the assumption feeding it is the part to check. Adding a null result on Sequence verification. I looked, carefully, and found…
-
Documentation that materially improves an appeal's chances Replied, post #63 · Access › Insurance & coverage · 14 Nov 2025 · 2 likes Coming back to post #59, because the follow-up matters more than the original answer. Reimbursement changes: a compound covered one year might not be the next. A…
-
Second pass at: The mass-error checker and its intended scope Replied, post #62 · Data & Tools › Calculators · 13 Nov 2025 · 6 likes Post #60 and I disagree about the size of the effect, not about the direction. A saved calculation is worth more than a remembered one. Write down the inputs alongside…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #41 · Compounds › Oral incretins · 12 Nov 2025 · 9 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #28 · Analytics › Method validation · 31 Oct 2025 · 29 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #40 · Clinical › Special populations · 24 Oct 2025 · 0 likes Where I part company with post #36, and it is a narrow parting. Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is…
-
Payment mechanics and the recovery options that do not exist Replied, post #90 · Sourcing › Payments · 23 Oct 2025 · 2 likes Payment mechanics: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
-
Thyroid function tests during substantial weight change Replied, post #98 · Clinical › Bloodwork · 16 Oct 2025 · 0 likes Picking up post #97: that is the part I would want checked first. Adding a reference point for thyroid function tests during substantial. Mine is a single case,…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #70 · Start Here › How to Ask · 16 Oct 2025 · 32 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #8 · Practice › Side effects · 16 Oct 2025 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Reading a supplier's product description as a marketing document Replied, post #82 · Compounds › Other compounds · 10 Oct 2025 · 13 likes Post #80 and I disagree about the size of the effect, not about the direction. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Managing an unplanned gap in supply — what changed since Replied, post #82 · Access › Shortages · 8 Oct 2025 · 3 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #64 · Lounge › Off topic · 29 Sep 2025 · 15 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Sleep quality changes during weight loss — what changed since Replied, post #8 · Wellbeing › Sleep · 24 Sep 2025 · 1 like Adding the measurement that post #5 says would settle it. Caffeine and alcohol both affect sleep architecture and both change during a period of reduced intake without…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #72 · Practice › Administration · 21 Sep 2025 · 0 likes Post #70 put the caveat in the right place and I want to underline it. If you have to inject at a different time of day than usual, that is a much smaller perturbation…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #17 · Evidence › Study critique · 12 Sep 2025 · 5 likes Post #14 is the version of this I will quote in future. One addition. Generalisability and validity are separate axes. A trial can be internally impeccable and still…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #106 · Data & Tools › Datasets · 10 Sep 2025 · 1 like I read post #104 twice before replying, because I had assumed the opposite. Independent test results are the most valuable data this community collects, and they are…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #63 · Analytics › HPLC & UHPLC · 8 Sep 2025 · 15 likes This follows post #62 rather than contradicting it. I would put moderate confidence on the mainstream reading of Resolution and tailing factor and no more. That is not…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #10 · Analytics › Method validation · 22 Aug 2025 · 0 likes Adding what did not work for me on LOD and LOQ, since the failures never get written up and they are half the useful information.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #107 · Practice › Reconstitution · 17 Aug 2025 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Coming back to: What happens when a maintainer goes quiet Replied, post #6 · Documentation › Doc review · 2 Aug 2025 · 8 likes I read post #5 twice before replying, because I had assumed the opposite. Where the review finds the content is right but the framing overstates it, that is the most…
-
Asking about a compound your prescriber has not heard of Replied, post #80 · Clinical › Prescriber conversations · 30 Jun 2025 · 3 likes Post #78 put the caveat in the right place and I want to underline it. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #18 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 10 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #8 · Evidence › Meta-analyses · 21 Jun 2025 · 17 likes That is a fair summary of where the discussion has got to.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #103 · Nutrition & Training › Protein & intake · 16 Jun 2025 · 0 likes The thing about Tracking intake that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #43 · Nutrition & Training › Protein & intake · 8 Jun 2025 · 32 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
A side-effect grading scheme this community uses, and its limits Started this topic · Practice › Side effects · 4 Jun 2025 · 1 like Posting this under the heading it deserves: A side-effect grading scheme this community uses, and its limits Everything below is what sits behind that. Side-effect…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #60 · Outcomes › Body composition · 18 May 2025 · 0 likes Circumference measurements at marked sites, taken consistently, track composition change better than most people expect for the cost.
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #7 · Compounds › Secretagogues & GH axis · 16 May 2025 · 0 likes Adding the measurement that post #4 says would settle it. Trying to state the reading a rodent study position in a way that someone who disagrees would recognise as…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #23 · Evidence › Trials · 9 May 2025 · 4 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #148 · Sourcing › Regulatory · 9 May 2025 · 0 likes The arithmetic in post #146 is right; the assumption feeding it is the part to check. My experience of Research-use-only labelling contradicts the reply above. I am…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #25 · Practice › Administration · 6 May 2025 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Fibre intake when total intake falls, and the constipation link Replied, post #57 · Nutrition & Training › Protein & intake · 22 Apr 2025 · 22 likes Practical experience of fibre intake, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Charge states for a 4 kDa peptide, worked through Replied, post #122 · Analytics › Mass spectrometry · 16 Mar 2025 · 5 likes The thing about charge states that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #28 · Sourcing › Vendor reports · 15 Mar 2025 · 8 likes Post #27 is right about the mechanism and I think understates the practical bit. Reports of ordinary results are more valuable than reports of remarkable ones,…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #31 · Clinical › Comorbidities · 11 Mar 2025 · 0 likes Answering the question post #29 raises rather than the one it answers. Two questions I would want answered before drawing anything from the obstructive sleep apnoea…
-
Consistent declarations and why they matter more than clever ones Replied, post #160 · Sourcing › Logistics · 10 Mar 2025 · 1 like Building on post #159 rather than restating it. A note on scope: what I am saying about consistent declarations applies to the case in the first post and I would not…
-
Charge states for a 4 kDa peptide, worked through Replied, post #42 · Analytics › Mass spectrometry · 7 Mar 2025 · 10 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #26 · Clinical › Comorbidities · 4 Mar 2025 · 32 likes Practical note on obstructive sleep apnoea: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance…
-
Coverage for the indication versus for the drug — a second dataset Started this topic · Access › Insurance & coverage · 3 Mar 2025 · 12 likes On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. Posting a small dataset on…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #27 · Compounds › Other compounds · 2 Mar 2025 · 1 like Anything in this subcategory with a published trial behind it should be discussed separately from anything without one. Mixing them produces a discussion where the…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #61 · Compounds › Semaglutide · 12 Feb 2025 · 0 likes Adding the measurement that post #60 says would settle it. The version of published dose-response for semaglutide that I was taught turned out to be a teaching…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #25 · Sourcing › Vendor reports · 22 Jan 2025 · 0 likes Include the sample handling: how it was stored, how it travelled to the laboratory, how long it sat. A result on badly handled material is measuring the handling. That…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #6 · Access › International · 20 Jan 2025 · 3 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them.
-
What changed in 2026, by region Replied, post #83 · Access › International · 17 Jan 2025 · 8 likes This follows post #81 rather than contradicting it. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #12 · Compounds › Other compounds · 12 Jan 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #23 · Evidence › Journal club · 10 Jan 2025 · 0 likes I would put moderate confidence on the mainstream reading of STEP 4 and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
[2026 update] New subcategory: rationale and scope Replied, post #130 · Meta › Announcements · 8 Jan 2025 · 0 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. That is the shape of it. The detail is where I would…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #9 · Practice › Reconstitution · 7 Jan 2025 · 9 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #139 · Practice › Dosing & titration · 1 Jan 2025 · 14 likes Post #135 describes the usual case. This is about the unusual one. There is no published evidence about slower escalation because nobody studied it. That means the…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #78 · Evidence › Journal club · 1 Jan 2025 · 1 like STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #43 · Compounds › Semaglutide · 26 Dec 2024 · 0 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #9 · Compounds › Semaglutide · 18 Dec 2024 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Coming back to: When to suspect the method rather than the sample Replied, post #81 · Analytics › Method validation · 16 Dec 2024 · 5 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. The short answer was in the first…
-
Coming back to: When to suspect the method rather than the sample Replied, post #64 · Analytics › Method validation · 12 Dec 2024 · 3 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
Body image changing more slowly than the body Replied, post #6 · Wellbeing › Mental health · 10 Dec 2024 · 8 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #45 · Nutrition & Training › Protein & intake · 8 Dec 2024 · 0 likes Post #44 is right about the mechanism and I think understates the practical bit. Where intake has fallen a long way, protein is usually the first thing to fall because…
-
A promotion I argued against, and why I lost Replied, post #19 · Documentation › Doc review · 2 Dec 2024 · 25 likes Objections are genuinely wanted at this stage, because a bad promotion is much harder to undo than a bad reply. That is one dataset and I would not build a rule on it.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #80 · Analytics › Method validation · 25 Nov 2024 · 22 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Time to steady state after a dose increase Replied, post #59 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 33 likes Where I part company with post #55, and it is a narrow parting. Half-life determines how quickly concentration approaches steady state and does not determine what the…
-
US compounding rules and how they changed Replied, post #30 · Regional › North America · 18 Oct 2024 · 11 likes Post #27 is the version of this I will quote in future. One addition. Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #33 · Wellbeing › Mental health · 15 Oct 2024 · 0 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only. Adding a source would improve…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #24 · Practice › Administration · 12 Sep 2024 · 0 likes Narrowing post #21, because the general version has more than one answer. The strongest argument against my own position on site rotation scheme, stated as well as I…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #14 · Sourcing › Independent verification · 24 Aug 2024 · 8 likes Building on post #12 rather than restating it. Answering the Splitting a vial question as asked, then the question I think is meant. As asked: yes, with the…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #13 · Compounds › Semaglutide · 19 Aug 2024 · 0 likes Picking up post #12: that is the part I would want checked first. Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The…
-
How to ask for a dose change without antagonising anyone Replied, post #10 · Clinical › Prescriber conversations · 31 Jul 2024 · 33 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
What happens when a maintainer goes quiet Replied, post #6 · Documentation › Doc review · 20 Jun 2024 · 31 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…